Cargando…

Primary Thromboprophylaxis in Ambulatory Pancreatic Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Patients with pancreatic cancer (PC) carry the highest risk of venous thromboembolism (VTE) amongst all cancer patients. Appropriate use of primary thromboprophylaxis might significantly and safely reduce its burden. We performed a systematic review of published studies and meeting abstracts using M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frere, Corinne, Crichi, Benjamin, Bournet, Barbara, Canivet, Cindy, Abdallah, Nassim Ait, Buscail, Louis, Farge, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464699/ https://www.ncbi.nlm.nih.gov/pubmed/32722064 http://dx.doi.org/10.3390/cancers12082028

Ejemplares similares

Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented
por: Farge, Dominique, et al.
Publicado: (2020)

Endoscopic ultrasound as a reliable tool for assessment of pancreatic adenocarcinoma treatment: Example of in situ gene therapy
por: Buscail, Louis, et al.
Publicado: (2022)

Pancreatic Cancer in Chronic Pancreatitis: Pathogenesis and Diagnostic Approach
por: Le Cosquer, Guillaume, et al.
Publicado: (2023)

A New Score to Predict the Resectability of Pancreatic Adenocarcinoma: The BACAP Score
por: Maulat, Charlotte, et al.
Publicado: (2020)

Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes
por: Rouanet, Marie, et al.
Publicado: (2017)

Hemostasis testing in patients with liver dysfunction: Advantages and caveats
por: Nguyen, Guillaume, et al.
Publicado: (2021)

Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges
por: Farge, Dominique, et al.
Publicado: (2019)

Molecular Endoscopic Ultrasound for Diagnosis of Pancreatic Cancer
por: Bournet, Barbara, et al.
Publicado: (2011)

A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort
por: Canivet, Cindy, et al.
Publicado: (2018)

KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
por: Bournet, Barbara, et al.
Publicado: (2016)

Salivary MicroRNA in Pancreatic Cancer Patients
por: Humeau, Marine, et al.
Publicado: (2015)

Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?
por: Frere, Corinne, et al.
Publicado: (2020)

P1646: A SYSTEMATIC REVIEW AND META‐ANALYSIS OF RANDOMIZED CONTROLLED TRIALS ON PRIMARY AMBULATORY THROMBOPROPHYLAXIS (PATP) IN PATIENTS WITH LYMPHOMA RECEIVING CHEMOTHERAPY
por: Htut, Thura, et al.
Publicado: (2023)

The Ottawa Score Performs Poorly to Identify Cancer Patients at High Risk of Recurrent Venous Thromboembolism: Insights from the TROPIQUE Study and Updated Meta-Analysis
por: Frere, Corinne, et al.
Publicado: (2022)

Management of Cancer-Associated Thrombosis: An Evolving Area
por: Frere, Corinne, et al.
Publicado: (2020)

Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges
por: Frere, Corinne, et al.
Publicado: (2019)

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
por: Nicolle, Rémy, et al.
Publicado: (2020)

Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?
por: Mulder, Frits I., et al.
Publicado: (2020)

Increased dose primary thromboprophylaxis in ambulatory patients with advanced pancreatic ductal adenocarcinoma, a single centre cohort study
por: Maraveyas, Anthony, et al.
Publicado: (2020)

How to screen and diagnose deep venous thrombosis (DVT) in patients hospitalized for or suspected of COVID-19 infection, outside the intensive care units
por: Sebuhyan, M., et al.
Publicado: (2020)

Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis
por: Sakka, M., et al.
Publicado: (2020)

Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous Polyposis
por: Le Cosquer, Guillaume, et al.
Publicado: (2022)

Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre‐specified subgroup analysis of the randomized CASSINI study
por: Vadhan‐Raj, Saroj, et al.
Publicado: (2020)

Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials
por: Frere, Corinne, et al.
Publicado: (2022)

Adipose-Derived Stem Cells in the Treatment of Perianal Fistulas in Crohn’s Disease: Rationale, Clinical Results and Perspectives
por: Buscail, Etienne, et al.
Publicado: (2021)

Perineal Wound Closure Following Abdominoperineal Resection and Pelvic Exenteration for Cancer: A Systematic Review and Meta-Analysis
por: Buscail, Etienne, et al.
Publicado: (2021)

Identification of hypercoagulability with thrombelastography in patients with hip fracture receiving thromboprophylaxis
por: You, Daniel, et al.
Publicado: (2021)

Cost–utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer
por: Kimpton, Miriam, et al.
Publicado: (2021)

Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes
por: Hammami, Rania, et al.
Publicado: (2022)

Burden of venous thromboembolism in patients with pancreatic cancer
por: Frere, Corinne
Publicado: (2021)

Incidence of Venous Thromboembolism in Hospitalized COVID-19 Patients Receiving Thromboprophylaxis
por: Huang, Jimmy, et al.
Publicado: (2022)

Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy
por: Papadopoulou, Aggeliki, et al.
Publicado: (2022)

Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA
por: Amintas, Samuel, et al.
Publicado: (2021)

Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
por: Willems, R. A. L., et al.
Publicado: (2023)

Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation
por: Pugnet, Grégory, et al.
Publicado: (2022)

Outcomes following pancreatic surgery using three different thromboprophylaxis regimens
por: Hanna‐Sawires, R. G., et al.
Publicado: (2019)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma
por: Buscail, Etienne, et al.
Publicado: (2019)

Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis
por: Li, Guowei, et al.
Publicado: (2016)

Overuse and underuse of thromboprophylaxis in medical inpatients
por: Kocher, Barbara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ht4ipa6dr48q9b55o11kbf9a5